PhRMA Statement on SCOTUS Ruling

Washington, D.C. (June 28, 2012) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John J. Castellani issued the following statement today:

Growth Platform For Economies Around the World

Medicare Part D At Age Five: What has Happened to Seniors' Prescription Drug Prices

PhRMA Statement Supporting U.S. Economic Recovery Advisers

Washington, D.C. (Jan. 21, 2011) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John Castellani issued the following statement today regarding the President’s new economic recovery advisory board:

“PhRMA commends President Obama for establishing a new Council on Jobs and Competitiveness, to be led by General Electric Chief Executive Officer Jeffrey R. Immelt.

Improving Prescription Medicine Adherence

Backgrounder: Improving Prescription Medication Adherence is Key to Better Health Care

Driving State Economic Growth in the 21st Century: Advancing the Biopharmaceutical Sector Report

Driving State Economic Growth in the 21st Century Executive Summary

PhRMA Statement on Health Care Reform

Washington, D.C. (March 25, 2010) – The Pharmaceutical Research and Manufacturers of America (PhRMA) issued the following statement on passage of comprehensive health care reform and accompanying reconciliation legislation:

“We believe comprehensive health care reform will benefit patients and the future of America. That’s why we have been involved in this important public policy debate for more than a year and why we supported the final health care reform bill and the amendments found in the reconciliation legislation.

PhRMA Statement on Senate Health Care Reform Bill

Washington, D.C. (December 24, 2009) – Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Ken Johnson released the following statement about the Senate health care reform bill:

Pages

Subscribe to RSS - Value